Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction for Oka et al., "In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile".
Oka D, Yamaya N, Kuno T, Asakawa Y, Shiragiku T, Chen L, Xue J, Mamuti A, Ye F, Sun J, Ohguro K, Miyamoto H, Uematsu Y, Inagaki K, Cheng JF, Matsumoto M. Oka D, et al. Among authors: shiragiku t. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0233821. doi: 10.1128/aac.02338-21. Epub 2022 Mar 15. Antimicrob Agents Chemother. 2022. PMID: 35289646 Free PMC article. No abstract available.
In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile.
Oka D, Yamaya N, Kuno T, Asakawa Y, Shiragiku T, Chen L, Xue J, Mamuti A, Ye F, Sun J, Ohguro K, Miyamoto H, Uematsu Y, Inagaki K, Cheng JF, Matsumoto M. Oka D, et al. Among authors: shiragiku t. Antimicrob Agents Chemother. 2021 Mar 18;65(4):e01170-20. doi: 10.1128/AAC.01170-20. Print 2021 Mar 18. Antimicrob Agents Chemother. 2021. PMID: 33495229 Free PMC article.
In vitro clastogenicity of optical isomers of nadifloxacin.
Takahashi N, Shiragiku T, Itoh T, Kaneko E, Shibahara T, Kanbe T, Yamashita S. Takahashi N, et al. Among authors: shiragiku t. Arzneimittelforschung. 1994 Nov;44(11):1265-8. Arzneimittelforschung. 1994. PMID: 7848343
Nonclinical safety profile of tolvaptan.
Oi A, Morishita K, Awogi T, Ozaki A, Umezato M, Fujita S, Hosoki E, Morimoto H, Ishiharada N, Ishiyama H, Uesugi T, Miyatake M, Senba T, Shiragiku T, Nakagiri N, Ito N. Oi A, et al. Among authors: shiragiku t. Cardiovasc Drugs Ther. 2011 Dec;25 Suppl 1:S91-9. doi: 10.1007/s10557-011-6356-y. Cardiovasc Drugs Ther. 2011. PMID: 22120097